Keyphrases
PARP Inhibitor (PARPi)
100%
In Cancer
100%
Cancer Therapy
100%
Mechanism of Action
14%
Cancer Cells
14%
Clinical Investigation
14%
Design Strategy
14%
Clinical Application
14%
Clinical Significance
14%
DNA Repair Enzymes
14%
Base Excision Repair Pathway
14%
Anticancer Drugs
14%
Drug Resistance
14%
Ovarian Cancer
14%
Anticancer Target
14%
Homologous Recombination Repair Defects
14%
Olaparib
14%
Critical DNA
14%
BRCA mutation
14%
Medicine and Dentistry
Cancer Therapy
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
100%
Cancer Cell
14%
Biological Marker
14%
Base Excision Repair
14%
DNA Ligase
14%
Anticarcinogen
14%
Drug Resistance
14%
Ovarian Cancer
14%
Recombination Repair
14%
Homologous Recombination
14%
Olaparib
14%
BRCA Mutation
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
100%
Biological Marker
14%
Base
14%
Anticarcinogen
14%
DNA Ligase
14%
Drug Resistance
14%
Ovary Cancer
14%
Olaparib
14%